Riverbridge Partners LLC Glaukos Corp Transaction History

Riverbridge Partners LLC

$5.98 Billion
Q2 2025

A detailed history of Riverbridge Partners LLC transactions in Glaukos Corp stock. As of the latest transaction made, Riverbridge Partners LLC holds 403,971 shares of GKOS stock, worth $36.1 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares

403,971

Previous 285,462 41.51%

Holding current value

$36.1 Million

Previous $28.1 Million 48.52%

% of portfolio

0.7%

Previous 0.47%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 15, 2025	BUY	$82.27 - $103.29 $9.75 Million - $12.2 Million	118,509 Added 41.51%	403,971 $41.7 Million
Q1 2025 Apr 21, 2025	SELL	$96.6 - $161.22 $2.65 Million - $4.43 Million	-27,469 Reduced 8.78%	285,462 $28.1 Million
Q4 2024 Jan 17, 2025	SELL	$126.42 - $152.67 $20.7 Million - $25 Million	-163,751 Reduced 34.35%	312,931 $46.9 Million
Q3 2024 Oct 15, 2024	SELL	$113.62 - $135.39 $1.86 Million - $2.22 Million	-16,393 Reduced 3.32%	476,682 $62.1 Million
Q2 2024 Jul 17, 2024	SELL	$89.48 - $118.35 $3.71 Million - $4.9 Million	-41,439 Reduced 7.75%	493,075 $58.4 Million
Q1 2024 Apr 26, 2024	SELL	$76.4 - $96.33 $1.04 Million - $1.31 Million	-13,622 Reduced 2.49%	534,514 $50.4 Million
Q4 2023 Feb 15, 2024	SELL	$59.53 - $85.11 $616,195 - $880,973	-10,351 Reduced 1.85%	548,136 $43.6 Million
Q4 2023 Jan 24, 2024	SELL	$59.53 - $85.11 $607,801 - $868,973	-10,210 Reduced 1.85%	541,078 $43 Million
Q3 2023 Feb 15, 2024	BUY	$69.23 - $79.09 $1.21 Million - $1.38 Million	17,409 Added 3.22%	558,487 $42 Million
Q3 2023 Oct 16, 2023	SELL	$69.23 - $79.09 $1.18 Million - $1.35 Million	-17,076 Reduced 3.0%	551,288 $41.5 Million
Q2 2023 Jul 25, 2023	SELL	$45.44 - $71.21 $524,695 - $822,261	-11,547 Reduced 1.99%	568,364 $40.5 Million
Q1 2023 Apr 21, 2023	SELL	$43.88 - $52.48 $828,673 - $991,084	-18,885 Reduced 3.15%	579,911 $29.1 Million
Q4 2022 Jan 11, 2023	SELL	$40.82 - $57.75 $525,108 - $742,896	-12,864 Reduced 2.1%	598,796 $26.2 Million
Q3 2022 Oct 26, 2022	SELL	$46.84 - $58.49 $101,549 - $126,806	-2,168 Reduced 0.35%	611,660 $32.6 Million
Q2 2022 Aug 29, 2022	SELL	$34.86 - $63.77 $981,169 - $1.79 Million	-28,146 Reduced 4.38%	613,828 $27.9 Million
Q2 2022 Jul 11, 2022	BUY	$34.86 - $63.77 $297,111 - $543,511	8,523 Added 1.35%	641,974 $29.2 Million
Q1 2022 Apr 20, 2022	BUY	$44.33 - $57.82 $3.5 Million - $4.56 Million	78,896 Added 14.23%	633,451 $36.6 Million
Q4 2021 Jan 14, 2022	BUY	$40.27 - $56.99 $327,153 - $462,986	8,124 Added 1.49%	554,555 $24.6 Million
Q3 2021 Oct 26, 2021	SELL	$47.43 - $84.23 $58,196 - $103,350	-1,227 Reduced 0.22%	546,431 $26.3 Million
Q2 2021 Jul 26, 2021	BUY	$73.06 - $97.7 $40 Million - $53.5 Million	547,658 New	547,658 $46.5 Million

Others Institutions Holding GKOS

# of Institutions

345

Shares Held

52.7M

Call Options Held

250K

Put Options Held

771K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $4.25B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverbridge Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Riverbridge Partners LLC with notifications on news.

Account

Riverbridge Partners LLC Glaukos Corp Transaction History